Genomtec SA(PL:GMT)
zł 2.66+0.25 (+8.79%)
PL:GMT
Genomtec SA financials statements
zł 2.66
At close:+0.25 (+8.79%)
Genomtec SA (GMT) Ratios
0 Followers
Genomtec SA Ratios
PL:GMT's free cash flow for Q2 2026 was zł1.24M. For the 2026 fiscal year, PL:GMT's free cash flow was decreased by zł-12.00K and operating cash flow was zł1.25M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.26 | 1.55 | 2.11 | 2.15 | 0.88 |
| Quick Ratio | 2.26 | 1.55 | 2.11 | 2.10 | 0.80 |
| Cash Ratio | 1.15 | 1.22 | 1.33 | 1.78 | 0.54 |
| Solvency Ratio | -1.62 | -0.94 | -1.02 | -1.67 | -1.90 |
| Operating Cash Flow Ratio | -2.76 | -1.23 | -2.53 | -1.63 | -2.15 |
| Short-Term Operating Cash Flow Coverage | -25.93 | -16.18 | -20.34 | -10.15 | -22.56 |
| Net Current Asset Value | zł 4.59M | zł -952.00K | zł -1.02M | zł -1.88M | zł -1.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.16 | 0.12 | 0.19 | 0.41 |
| Debt-to-Equity Ratio | 0.20 | 0.36 | 0.24 | 0.47 | 2.41 |
| Debt-to-Capital Ratio | 0.17 | 0.26 | 0.19 | 0.32 | 0.71 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.67 | 2.24 | 1.92 | 2.41 | 5.83 |
| Debt Service Coverage Ratio | -16.03 | -15.93 | -12.34 | -16.69 | -24.11 |
| Interest Coverage Ratio | -48.29 | -82.50 | -36.98 | -40.93 | -376.43 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.14 | 0.22 | 0.18 | 0.27 | 0.22 |
| Net Debt to EBITDA | 0.24 | 0.45 | 0.28 | 0.17 | -0.06 |
| Profitability Margins | |||||
| Gross Profit Margin | -13238.10% | 100.00% | -79300.00% | -2042.50% | -171.69% |
| EBIT Margin | -70371.43% | -1105500.00% | -891200.00% | -28730.00% | -3233.79% |
| EBITDA Margin | -57033.33% | -872500.00% | -775600.00% | -27640.00% | -3003.65% |
| Operating Profit Margin | -70371.43% | -1105500.00% | -872700.00% | -29882.50% | -4812.79% |
| Pretax Profit Margin | -49828.57% | -1118800.00% | -903100.00% | -29705.00% | -3246.58% |
| Net Profit Margin | -49671.43% | -1120800.00% | -901300.00% | -29820.00% | -3248.86% |
| Continuous Operations Profit Margin | -49671.43% | -1120800.00% | -901300.00% | -29820.00% | -3248.86% |
| Net Income Per EBT | 99.68% | 100.18% | 99.80% | 100.39% | 100.07% |
| EBT Per EBIT | 70.81% | 101.20% | 103.48% | 99.41% | 67.46% |
| Return on Assets (ROA) | -67.63% | -65.77% | -56.43% | -101.12% | -168.76% |
| Return on Equity (ROE) | -113.21% | -147.47% | -108.56% | -244.03% | -984.09% |
| Return on Capital Employed (ROCE) | -130.76% | -95.63% | -68.03% | -126.19% | -639.18% |
| Return on Invested Capital (ROIC) | -115.06% | -85.60% | -63.55% | -114.92% | -408.53% |
| Return on Tangible Assets | -93.74% | -100.69% | -107.02% | -164.71% | -169.77% |
| Earnings Yield | -18.22% | -10.69% | -6.82% | -10.96% | -9.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.50 | 0.06 | 1.34 |
| Payables Turnover | 2.89 | 2.98 | 0.85 | 0.95 | 1.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 8.16 | 3.04 |
| Fixed Asset Turnover | 0.01 | 0.00 | 0.00 | 0.02 | 0.11 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| Working Capital Turnover Ratio | 0.01 | 0.00 | 0.00 | 0.03 | 0.07 |
| Cash Conversion Cycle | 77427.54 | 640452.50 | 298.34 | 5912.46 | 29.80 |
| Days of Sales Outstanding | 77553.81 | 640575.00 | 730.00 | 6250.63 | 273.33 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 44.72 | 120.24 |
| Days of Payables Outstanding | 126.27 | 122.50 | 431.66 | 382.89 | 363.77 |
| Operating Cycle | 77553.81 | 640575.00 | 730.00 | 6295.34 | 393.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.76 | -0.50 | -0.65 | -0.40 | -0.68 |
| Free Cash Flow Per Share | -0.76 | -0.51 | -0.94 | -0.87 | -0.70 |
| Dividend Paid and CapEx Coverage Ratio | -123.74 | -113.83 | -2.25 | -0.87 | -25.95 |
| Capital Expenditure Coverage Ratio | -123.74 | -113.83 | -2.25 | -0.87 | -25.95 |
| Operating Cash Flow Coverage Ratio | -6.25 | -2.45 | -4.00 | -1.66 | -3.17 |
| Operating Cash Flow to Sales Ratio | -542.10 | -6716.00 | -7952.00 | -94.67 | -25.24 |
| Free Cash Flow Yield | -20.05% | -6.46% | -8.69% | -7.46% | -7.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.51 | -9.36 | -14.66 | -9.12 | -10.72 |
| Price-to-Sales (P/S) Ratio | 2725.98 | 104874.86 | 132150.07 | 2720.29 | 348.32 |
| Price-to-Book (P/B) Ratio | 6.21 | 13.80 | 15.92 | 22.26 | 105.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.99 | -15.48 | -11.51 | -13.40 | -13.29 |
| Price-to-Operating Cash Flow Ratio | -5.03 | -15.62 | -16.62 | -28.73 | -13.80 |
| Price-to-Earnings Growth (PEG) Ratio | 0.31 | -0.69 | 0.35 | -0.20 | 0.31 |
| Enterprise Value Multiple | -4.54 | -11.57 | -16.76 | -9.67 | -11.65 |
| Enterprise Value | 54.35M | 100.91M | 129.97M | 106.95M | 76.65M |
| EV to EBITDA | -4.54 | -11.57 | -16.76 | -9.67 | -11.65 |
| EV to Sales | 2587.89 | 100913.86 | 129969.07 | 2673.79 | 349.98 |
| EV to Free Cash Flow | -4.74 | -14.90 | -11.32 | -13.17 | -13.35 |
| EV to Operating Cash Flow | -4.77 | -15.03 | -16.34 | -28.24 | -13.86 |
| Tangible Book Value Per Share | 0.43 | 0.13 | 0.06 | 0.04 | 0.09 |
| Shareholders’ Equity Per Share | 0.61 | 0.57 | 0.68 | 0.52 | 0.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Net Income Per Share | -0.69 | -0.84 | -0.74 | -1.27 | -0.87 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.71 | 1.01 | 1.01 | 1.03 | 1.00 |
| Research & Development to Revenue | 265.71 | 4310.00 | 793.00 | 81.00 | 22.06 |
| SG&A to Revenue | 305.62 | 4150.00 | 9430.00 | 214.20 | 23.52 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 120.75 | 0.00 |
| Income Quality | 1.09 | 0.60 | 0.88 | 0.32 | 0.78 |
Currency in PLN
